Back to mobile site

Medivation (MDVN) Announces Filing of Consent Revocation Statement in Response to Sanofi (SNY)

May 27, 2016 8:09 AM EDT Send to a Friend
Medivation, Inc. (Nasdaq: MDVN) announced that it has filed a preliminary Consent Revocation Statement with the Securities and Exchange Commission ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login